Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient With Schizophrenia Spectrum Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05933356
What this trial is testing

Effectiveness of Exergames on Cognitive, Social Functionamong Chronic Schizophrenia

Who this might be right for
Gambling
Kaohsiung Medical University Chung-Ho Memorial Hospital 154
Large-scale testing (Phase 3)Study completedNCT01683058
What this trial is testing

Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 74
Not applicableStudy completedNCT04870996
What this trial is testing

RCT of tDCS Combined With Cognitive Training in Schizophrenia

Who this might be right for
Schizophrenia
CHAN SAU MAN, SANDRA 44
Testing effectiveness (Phase 2)Study completedNCT02281773
What this trial is testing

Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment.

Who this might be right for
Schizophrenia
Boehringer Ingelheim 518
Large-scale testing (Phase 3)UnknownNCT01672554
What this trial is testing

Clinical Benefits of Seroquel XR in Anxiety Disorder

Who this might be right for
SchizophreniaAnxiety
Corporation de Recherche en Neuropsycho Pharmacologie de Quebec 40
Testing effectiveness (Phase 2)Ended earlyNCT00669903
What this trial is testing

Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 100
Testing effectiveness (Phase 2)Ended earlyNCT00548327
What this trial is testing

The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype

Who this might be right for
SchizophreniaMemory DisordersCognition Disorders
National Institute of Mental Health (NIMH) 11
Early research (Phase 1)Study completedNCT06276361
What this trial is testing

Pharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone (QUAR) in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Rovi Pharmaceuticals Laboratories 58
Not applicableUnknownNCT00172770
What this trial is testing

The Establishment of the Early Intervention Program for Patients With Schizophrenia

Who this might be right for
Schizophrenia
National Taiwan University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT01234779
What this trial is testing

RO4917838 (Bitopertin) in Patients With Acute Exacerbation of Schizophrenia

Who this might be right for
Schizophrenia
Hoffmann-La Roche 301
Large-scale testing (Phase 3)Study completedNCT01515423
What this trial is testing

Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With Schizophrenia

Who this might be right for
Schizophrenia
Janssen Research & Development, LLC 1,429
Large-scale testing (Phase 3)Study completedNCT00472862
What this trial is testing

Neurocognitive Training Integrated in OPUS Treatment Versus OPUS Treatment-as-usual

Who this might be right for
Schizophrenia
Neurocom 117
Not applicableStudy completedNCT00689325
What this trial is testing

Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical Antipsychotics

Who this might be right for
Schizophrenia
AstraZeneca 158
Post-approval studies (Phase 4)Study completedNCT00308360
What this trial is testing

Risperidone Alone Vs. Risperidone Plus Valproate in the Treatment of Patients With Schizophrenia and Hostility

Who this might be right for
Schizophrenia
Nathan Kline Institute for Psychiatric Research 46
Post-approval studies (Phase 4)Study completedNCT00573417
What this trial is testing

A Placebo-Controlled Trial of Modafinil (Provigil) Added to Clozapine in Patients With Schizophrenia

Who this might be right for
Schizophrenia
North Suffolk Mental Health Association 40
Testing effectiveness (Phase 2)Ended earlyNCT03044249
What this trial is testing

MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

Who this might be right for
PsychosisDementiaAggression+2 more
Mediti Pharma Inc. 81
Post-approval studies (Phase 4)Study completedNCT01050478
What this trial is testing

IMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute Agitation

Who this might be right for
Psychomotor AgitationAcute Disease
Janssen Cilag N.V./S.A. 56
Not applicableUnknownNCT05769933
What this trial is testing

Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging

Who this might be right for
HealthyEpilepsyPsychosis+1 more
CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et Developpement 156
Large-scale testing (Phase 3)Ended earlyNCT00660595
What this trial is testing

Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose

Who this might be right for
Schizophrenic Disorders
AstraZeneca 29
Not applicableUnknownNCT00698295
What this trial is testing

Linear and Non-linear Analysis of EEG Changes in Schizophrenia After Atypical Antipsychotics Medication

Who this might be right for
Schizophrenia
Seoul National University Hospital 60
Next Page